See also this year's filing and all EDGAR filings for this company.
PDF Report 0001087294_2018_Cumberland_Pharmaceuticals_INC.pdf
Logs
Graph
Absolute values for 0001087294, Cumberland Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 68,684,845 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 21,444,545 |
| 2 | PropertyPlantAndEquipmentNet | 528,882 |
| 3 | remainder_Assets | 2,574,040 |
| 4 | LiabilitiesCurrent | 17,694,743 |
| 5 | LiabilitiesNoncurrent | 1,815,968 |
| 6 | remainder_Liabilities | 9,800,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 10,032,106 |
| 9 | ResearchAndDevelopmentExpense | 3,847,131 |
| 10 | remainder_Expenses | 34,668,222 |
| 11 | remainder_Revenues | 40,682,619 |
| 12 | remainder_NetIncome | 318,092 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 93,232,312 |
| 1 | Liabilities | 29,310,711 |
| 2 | Expenses | 48,547,459 |
| 3 | Revenues | 40,682,619 |
| 4 | StockholdersEquity | 63,921,601 |
| 5 | NetIncome | -7,546,748 |
| 6 | ComprehensiveNetIncome | -7,546,748 |
| 7 | BaseVar | 106,045,596 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.15 |
| 9 | EconomicCapitalRatio | 3.13 |
Edgar->Model Mapping
Feature Distribution
Change over Time
